1.Cardiac Physiologic Regulation of Sub-type Specific Adrenergic Receptors in Transgenic Mice Overexpressing β1- and β2-Adrenergic Receptors.
Ka Eul KIM ; Hyun Jin TAE ; Petrashevskaya NATALIA ; Jae Chul LEE ; Ji Hyeon AHN ; Joon Ha PARK ; In Hye KIM ; Taek Geun OHK ; Chan Woo PARK ; Jun Hwi CHO ; Moo Ho WON
Journal of the Korean Society of Emergency Medicine 2017;28(2):201-207
PURPOSE: A combination of β1-adrenergic receptor (β₁-AR) blockade and β₂-AR activation might potentially be the novel therapy for treating heart failure. However, the use of β-AR agonists and/or antagonists in the clinical setting is controversial due to the lack of information on cardiac inotropic or chronotropic regulation by AR signaling. METHODS: In this study, we performed a hemodynamic evaluation by examining the force frequency response (FFR), Frank-Starling relationship, and response to non-selective β-AR agonist (isoproterenol) in the hearts isolated from 6-month-old transgenic (TG) mice overexpressing β₁- and β₂-ARs (β₁- and β₂-AR TG mice, respectively). RESULTS: Cardiac physiologic consequences of β₁- and β₂-AR overexpression resulted in a similar maximal response to that of isoproterenol and faster temporary decline of positive inotropic response in β₂-AR TG mice. β₁-AR TG mice showed a pronounced negative limb of FFR, whereas β2-AR TG mice showed high stimulation frequencies with low contractile depression during FFR. Contrastingly, Frank-Starling relationship was equally enhanced in both β₁- and β₂-AR TG mice. CONCLUSION: Hemodynamic evaluation performed in the present study showed a difference between β₁- and β₂-AR signaling, which may be due to a difference in the desensitization of β₁- and β₂-ARs.
Animals
;
Depression
;
Extremities
;
Heart
;
Heart Failure
;
Hemodynamics
;
Humans
;
Infant
;
Isoproterenol
;
Mice
;
Mice, Transgenic*
;
Receptors, Adrenergic*
2.Cardiac physiologic regulation of sub-type specific adrenergic receptors in transgenic mice overexpressing β₁- and β₂-adrenergic receptors.
Ka Eul KIM ; Hyun Jin TAE ; Petrashevskaya NATALIA ; Jae Chul LEE ; Ji Hyeon AHN ; Joon Ha PARK ; In Hye KIM ; Taek Geun OHK ; Chan Woo PARK ; Jun Hwi CHO ; Moo Ho WON
Clinical and Experimental Emergency Medicine 2016;3(3):175-180
OBJECTIVE: Combination of β₁-adrenergic receptor (AR) blockade and β₂-AR activation might be a potential novel therapy for treating heart failure. However, use of β-AR agonists and/or antagonists in the clinical setting is controversial because of the lack of information on cardiac inotropic or chronotropic regulation by AR signaling. METHODS: In this study, we performed hemodynamic evaluation by examining force frequency response (FFR), Frank-Starling relationship, and response to a non-selective β-AR agonist (isoproterenol) in hearts isolated from 6-month-old transgenic (TG) mice overexpressing β₁- and β₂-ARs (β₁- and β₂-AR TG mice, respectively). RESULTS: Cardiac physiologic consequences of β₁- and β₂-AR overexpression resulted in similar maximal response to isoproterenol and faster temporary decline of positive inotropic response in β₂-AR TG mice. β₁-AR TG mice showed a pronounced negative limb of FFR, whereas β₂-AR TG mice showed high stimulation frequencies with low contractile depression during FFR. In contrast, Frank-Starling relationship was equally enhanced in both β₁- and β₂-AR TG mice. CONCLUSION: Hemodynamic evaluation performed in the present showed a difference in β₁- and β₂-AR signaling, which may be due to the difference in the desensitization of β₁- and β₂-ARs.
Animals
;
Depression
;
Extremities
;
Heart
;
Heart Failure
;
Hemodynamics
;
Humans
;
Infant
;
Isoproterenol
;
Mice
;
Mice, Transgenic*
;
Receptors, Adrenergic*